TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: 0.000500nMAssay Description:In vitro activity evaluation: Cisbio PD-1/PD-L1 binding assay kit was applied for the detection method of in vitro enzymology level.Screening Princip...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1 [25-167,N33K], Immunoglobulin heavy constant gamma 1 [99-330,C104S,C109S,C112S,L118I,P121S]/Programmed cell death 1 ligand 1 [18-239,H172E](Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 2nMAssay Description:The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1 [25-167,N33K], Immunoglobulin heavy constant gamma 1 [99-330,C104S,C109S,C112S,L118I,P121S]/Programmed cell death 1 ligand 1 [18-239,H172E](Homo sapiens (Human))
Bristol-Myers Squibb
US Patent
Bristol-Myers Squibb
US Patent
Affinity DataIC50: 4nMAssay Description:The ability of the macrocyclic peptides of the present disclosure to bind to PD-L1 was investigated using a PD-1/PD-L1 Homogenous Time-Resolved Fluor...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair
TargetProgrammed cell death protein 1(Homo sapiens)
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Institute Of Materia Medica, Chinese Academy Of Medical Sciences
US Patent
Affinity DataIC50: <5nMAssay Description:96 Well plates were coated with 1 g/mL of human PD-L1 (obtained from R&D) in PBS overnight at 4° C. The wells were then blocked with 2% BSA in PBS (W...More data for this Ligand-Target Pair